title: Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.
authors.affiliation: Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
authors.forename: Q
authors.initials: Q
authors.lastname: Jiang
authors.forename: L-P
authors.initials: LP
authors.lastname: Xu
authors.forename: D-H
authors.initials: DH
authors.lastname: Liu
authors.forename: K-Y
authors.initials: KY
authors.lastname: Liu
authors.forename: R P
authors.initials: RP
authors.lastname: Gale
authors.forename: M-J
authors.initials: MJ
authors.lastname: Zhang
authors.forename: B
authors.initials: B
authors.lastname: Jiang
authors.forename: X-H
authors.initials: XH
authors.lastname: Zhang
authors.forename: Y
authors.initials: Y
authors.lastname: Wang
authors.forename: S-S
authors.initials: SS
authors.lastname: Chen
authors.forename: X-Y
authors.initials: XY
authors.lastname: Zhao
authors.forename: H
authors.initials: H
authors.lastname: Chen
authors.forename: H
authors.initials: H
authors.lastname: Jiang
authors.forename: Y-H
authors.initials: YH
authors.lastname: Chen
authors.forename: W
authors.initials: W
authors.lastname: Han
authors.forename: Y-Z
authors.initials: YZ
authors.lastname: Qin
authors.forename: Y-R
authors.initials: YR
authors.lastname: Liu
authors.forename: Y-Y
authors.initials: YY
authors.lastname: Lai
authors.forename: M
authors.initials: M
authors.lastname: Lv
authors.forename: X-J
authors.initials: XJ
authors.lastname: Huang
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000601:surgery*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D035781:Siblings; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate